87854-001

Manufacturer
Tupelo Brittany LLC
Effective date
2026-07-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-07-25 05:10:06

Label at a glance#

ProductALORYXA
Active ingredientPOVIDONE-IODINE, PORK COLLAGEN, EPIGALLOCATECHIN GALLATE
Label structure12 sections

Dosage and administration

After washing your hands, open the package, remove the cap, and applyit to the intimate area. Discard applicator after one application.

Storage and handling

Avoid freezing Protect from direct sunlight and excessive heat above 40°C (104°F) Expiration date / lot number printed on packaging

Label contents#

Full prescribing information#

Active Ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Povidone-lodine 0.1% (w/w).
Collagen Porcine 0.02% (w/w).
Epigallocatechin Gallate 0.01% (w/w)

Purpose

OTC - PURPOSE SECTION

Antiseptic / Antimicrobial
Skin Protectant
Skin Protectant

Use

INDICATIONS & USAGE SECTION

1.Reduce vaginal microorganisms that may cause odor, discomfort, or imbalance

2.Provides gentle intimate care and temporary relief of mild irritation.

3.For intravaginal and external topical use.

Warnings

WARNINGS SECTION

For external and intravaginal use only

Do not use

OTC - DO NOT USE SECTION

1. if you are pregnant or in gestational periods
2. on scars, eczema, or dermatitis
3. if you have a known allergy to Benzalkonium Bromide or any listed ingredients

OTC - WHEN USING SECTION

1. After opening the cap, use the product immediately and do not reuse it.

2. avoid contact with eyes; if contact occurs, rinse thoroughly with water
3. mild temporary tingling may occur
2. do not share applicators

OTC - STOP USE SECTION

1. irritation, rash, red spot or discomfort occurs .

2.abnormal discharge, fever, pelvic pain, or foul odor develops (may be signs ofanother condition requiring medical attention)

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center Immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

After washing your hands, open the package, remove the cap, and applyit to the intimate area. Discard applicator after one application.

Other information

STORAGE AND HANDLING SECTION

Avoid freezing

Protect from direct sunlight and excessive heat above 40°C (104°F)

Expiration date / lot number printed on packaging

Inactive ingredients

INACTIVE INGREDIENT SECTION

Purified Water (Aqua), Glycerin, Carbomer, Propylene Glycol, Butylene Glycol, Triethanolamine, 1,2-Hexanediol, Glyceryl Glucoside,

Beta-Glucan of SchizophyllumCommune, Salvia Miltiorrhiza Root Extract, Curcuma Longa Root Extract, VitisVinifera Seed Extract, Sophora Flavescens Root Extract, Cnidium Monnieri Extract,Rheum Tanguticum Root Extract, Scutellaria Baicalensis Extract, AstragalusMembranaceus Mongholicus Extract, Hypericum Perforatum Extract, Centella Asiatica Extract, Arnebia Euchroma

Extract, Glycyrrhiza Uralensis (Licorice) Extract

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label

22

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87854-00187854-001-01, 87854-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 24 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALORYXAGYNECOLOGICAL INTIMATE CARE GELTupelo Brittany LLC57346a86-ab51-021a-e063-6394a90a1dc22026-07-22WarningsExact identifier
ndc (package): 87854-001-02
ndc (package): 87854-001-01
ndc (product): 87854-001
ndc11 (package): 87854000101
ndc11 (package): 87854000102
spl id: 57346a86-ab52-021a-e063-6394a90a1dc2
spl set id: 57346a86-ab51-021a-e063-6394a90a1dc2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.